Barclays’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 4337 |
|
|
2025
Q1 | $0 | Sell |
4
-34
| -89% | – | ﹤0.01% | 4370 |
|
|
2024
Q4 | $0 | Sell |
38
-976
| -96% | – | ﹤0.01% | 4351 |
|
|
2024
Q3 | $0 | Sell |
1,014
-102,051
| -99% | – | ﹤0.01% | 4313 |
|
|
2024
Q2 | $273K | Sell |
103,065
-28,601
| -22% | -$75.8K | ﹤0.01% | 2871 |
|
|
2024
Q1 | $361K | Sell |
131,666
-41,975
| -24% | -$115K | ﹤0.01% | 3017 |
|
|
2023
Q4 | $422K | Sell |
173,641
-262,200
| -60% | -$637K | ﹤0.01% | 3101 |
|
|
2023
Q3 | $880K | Buy |
435,841
+216,933
| +99% | +$438K | ﹤0.01% | 2178 |
|
|
2023
Q2 | $646K | Sell |
218,908
-17,210
| -7% | -$50.8K | ﹤0.01% | 2437 |
|
|
2023
Q1 | $590K | Buy |
236,118
+28,029
| +13% | +$70K | ﹤0.01% | 2529 |
|
|
2022
Q4 | $659K | Buy |
208,089
+41,321
| +25% | +$131K | ﹤0.01% | 2417 |
|
|
2022
Q3 | $495K | Buy |
166,768
+108,431
| +186% | +$322K | ﹤0.01% | 2599 |
|
|
2022
Q2 | $177K | Sell |
58,337
-2,781
| -5% | -$8.44K | ﹤0.01% | 3203 |
|
|
2022
Q1 | $826K | Buy |
+61,118
| New | +$826K | ﹤0.01% | 2453 |
|